Cimas FJ - Search Results

1

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.

Juan A, Cimas FJ, Bravo I, Pandiella A, Ocaña A, Alonso-Moreno C. Juan A, et al. Among authors: cimas fj. Int J Mol Sci. 2020 Aug 21;21(17):6018. doi: 10.3390/ijms21176018. Int J Mol Sci. 2020. PMID: 32825618 Free PMC article. Review.

2

ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Arias-González L, Moreno-Gimeno I, del Campo AR, Serrano-Oviedo L, Valero ML, Esparís-Ogando A, de la Cruz-Morcillo MÁ, Melgar-Rojas P, García-Cano J, Cimas FJ, Hidalgo MJ, Prado A, Callejas-Valera JL, Nam-Cha SH, Giménez-Bachs JM, Salinas-Sánchez AS, Pandiella A, del Peso L, Sánchez-Prieto R. Arias-González L, et al. Among authors: cimas fj. Neoplasia. 2013 Jun;15(6):649-59. doi: 10.1593/neo.121896. Neoplasia. 2013. PMID: 23730213 Free PMC article.

3

Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.

Alcaraz-Sanabria A, Baliu-Piqué M, Saiz-Ladera C, Rojas K, Manzano A, Marquina G, Casado A, Cimas FJ, Pérez-Segura P, Pandiella A, Gyorffy B, Ocana A. Alcaraz-Sanabria A, et al. Among authors: cimas fj. Front Oncol. 2020 Jan 10;9:1486. doi: 10.3389/fonc.2019.01486. eCollection 2019. Front Oncol. 2020. PMID: 31998644 Free PMC article.

4

Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1.

Cimas FJ, Manzano A, Baliu-Piqué M, García-Gil E, Pérez-Segura P, Nagy Á, Pandiella A, Győrffy B, Ocana A. Cimas FJ, et al. Cancers (Basel). 2020 Aug 11;12(8):2243. doi: 10.3390/cancers12082243. Cancers (Basel). 2020. PMID: 32796628 Free PMC article.

5

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy.

Juan A, Cimas FJ, Bravo I, Pandiella A, Ocaña A, Alonso-Moreno C. Juan A, et al. Among authors: cimas fj. Pharmaceutics. 2020 Aug 25;12(9):802. doi: 10.3390/pharmaceutics12090802. Pharmaceutics. 2020. PMID: 32854255 Free PMC article. Review.

6

Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer.

Cimas FJ, Niza E, Juan A, Noblejas-López MDM, Bravo I, Lara-Sanchez A, Alonso-Moreno C, Ocaña A. Cimas FJ, et al. Pharmaceutics. 2020 Oct 19;12(10):986. doi: 10.3390/pharmaceutics12100986. Pharmaceutics. 2020. PMID: 33086530 Free PMC article.

7

In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer.

Rojas K, Baliu-Piqué M, Manzano A, Saiz-Ladera C, García-Barberán V, Cimas FJ, Pérez-Segura P, Pandiella A, Győrffy B, Ocana A. Rojas K, et al. Among authors: cimas fj. Cell Oncol (Dordr). 2021 Jun;44(3):569-580. doi: 10.1007/s13402-020-00583-9. Epub 2021 Jan 19. Cell Oncol (Dordr). 2021. PMID: 33469836

8

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

Noblejas-López MDM, Baliu-Piqué M, Nieto-Jiménez C, Cimas FJ, Morafraile EC, Pandiella A, Corbi ÁL, Győrffy B, Ocaña A. Noblejas-López MDM, et al. Among authors: cimas fj. Int J Mol Sci. 2021 Apr 7;22(8):3836. doi: 10.3390/ijms22083836. Int J Mol Sci. 2021. PMID: 33917174 Free PMC article.

9

The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent.

Cuevas VD, Simón-Fuentes M, Orta-Zavalza E, Samaniego R, Sánchez-Mateos P, Escribese M, Cimas FJ, Bustos M, Pérez-Diego M, Ocaña A, Domínguez-Soto Á, Vega MA, Corbí ÁL. Cuevas VD, et al. Among authors: cimas fj. J Innate Immun. 2022;14(3):243-256. doi: 10.1159/000519305. Epub 2021 Oct 20. J Innate Immun. 2022. PMID: 34670213 Free PMC article.

10

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer.

Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno C. Domínguez-Jurado E, et al. Among authors: cimas fj. Pharmaceutics. 2021 Sep 26;13(10):1559. doi: 10.3390/pharmaceutics13101559. Pharmaceutics. 2021. PMID: 34683852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page